Labial (Cheek) Cancer - Symptoms, Causes, Treatment & Prevention

```html

Overview

Labial (cheek) cancer, also called buccal mucosa cancer, is a malignancy that arises from the cells lining the inner surface of the cheek (the buccal mucosa). It belongs to the broader group of oral cavity cancers, which account for about 3% of all cancers diagnosed in the United States each year.

• Incidence: Worldwide, oral cavity cancers affect roughly 300,000 new patients annually; of these, the buccal mucosa accounts for 5‑10%, depending on geographic region and cultural habits.<sup>[1][2]</sup>
• Age & gender: The median age at diagnosis is 55‑65 years. Men are 2‑3 times more likely than women to develop the disease, largely because of higher rates of tobacco and betel‑nut use.<sup>[3]</sup>
• Geographic variation: High‑incidence regions include South‑East Asia (India, Sri Lanka, Taiwan) where betel‑quid chewing is common, and parts of the Pacific Islands. In North America and Europe, the disease is less common but still seen in smokers and heavy alcohol users.<sup>[4]</sup>

Symptoms

Early lesions often cause few or no symptoms, which is why routine oral examinations are essential. When symptoms appear, they may include:

• Persistent ulcer or sore on the inner cheek that does not heal within 2‑3 weeks.
• Red or white patches (erythroplakia or leukoplakia) that may become ulcerated.
• Localized pain or tenderness, especially when eating, speaking, or brushing teeth.
• Bleeding from the lesion, either spontaneously or after minor trauma.
• Swelling or a lump that feels firm or hard to the touch.
• Difficulty opening the mouth (trismus) or moving the jaw.
• Changed sensation – numbness or tingling of the cheek or nearby lip.
• Persistent bad taste or odor in the mouth.
• Weight loss or loss of appetite due to pain while eating.
• Ear pain (referred pain) without ear pathology.

Because many of these signs overlap with benign conditions (e.g., aphthous ulcers, trauma), any unexplained lesion lasting longer than three weeks warrants professional evaluation.

Causes and Risk Factors

Primary Causes

• Tobacco use – cigarettes, cigars, pipes, and smokeless tobacco (chewing tobacco, snuff) deliver carcinogens directly to the oral mucosa.
• Betel‑nut (areca) chewing – often combined with tobacco and slaked lime, it is a potent risk factor in South‑East Asia.<sup>[5]</sup>
• Alcohol consumption – heavy, chronic intake synergizes with tobacco to dramatically increase risk.
• Human papillomavirus (HPV) – especially HPV‑16, though it is more strongly linked to oropharyngeal cancers than to buccal mucosa cancer.<sup>[6]</sup>

Additional Risk Factors

• Chronic irritants: ill‑fitting dentures, habitual cheek biting, or long‑standing mucosal trauma.
• Diet low in fruits and vegetables – antioxidants appear protective.
• Immunosuppression: HIV infection, organ‑transplant recipients.
• Genetic predisposition: certain polymorphisms in enzymes that metabolize tobacco carcinogens.
• Age >50 and male gender (as noted above).

Diagnosis

Diagnosis begins with a thorough history and oral examination by a dentist, oral surgeon, or otolaryngologist.

Clinical Evaluation

• Visual inspection with good lighting; use of a tongue depressor or mirror.
• Palpation of surrounding tissues, lymph nodes (submandibular, submental, cervical).
• Documentation of lesion size, color, surface, and fixation.

Procedures & Tests

1. Incisional or excisional biopsy – the gold standard. Tissue is sent for histopathology to confirm malignancy and grade (well, moderately, or poorly differentiated).<sup>[7]</sup>
2. Imaging – CT scan of head and neck, MRI for soft‑tissue detail, and PET‑CT for distant metastasis assessment.
3. Fine‑needle aspiration (FNA) of suspicious neck nodes.
4. Adjunctive tools – toluidine blue staining, autofluorescence, and brush cytology can help identify suspicious areas but are not definitive.
5. Staging – AJCC 8th edition TNM system is used to classify tumor size (T), nodal involvement (N), and metastasis (M). This guides treatment planning.

Treatment Options

Treatment is individualized based on tumor stage, patient health, and functional considerations (speech, swallowing). Multidisciplinary care (head‑and‑neck surgeon, radiation oncologist, medical oncologist, speech therapist, dietitian) yields the best outcomes.

Surgical Management

• Wide local excision with 1‑2 cm margins is the mainstay for early‑stage (T1‑T2) disease.
• Segmental resection or composite resection may be required for larger tumors invading deeper structures.
• Neck dissection when clinically or radiologically positive lymph nodes are present.
• Reconstruction (local flaps, free‑tissue transfer) to preserve oral function.

Radiation Therapy

• Definitive radiotherapy (≥66 Gy) for patients who are not surgical candidates.
• Adjuvant (post‑operative) radiation for close/positive margins, perineural invasion, or nodal disease.
• Intensity‑Modulated Radiation Therapy (IMRT) reduces dose to salivary glands and improves quality of life.

Chemotherapy & Targeted Therapy

• Concurrent chemoradiation using cisplatin is standard for advanced (Stage III‑IV) lesions.
• For recurrent/metastatic disease:
  • Platinum‑based doublets (cisplatin + 5‑FU or docetaxel).
  • Targeted agents such as cetuximab (EGFR inhibitor) when EGFR over‑expression is documented.
  • Immunotherapy (PD‑1 inhibitors like pembrolizumab or nivolumab) for PD‑L1‑positive tumors, per recent NCCN guidelines.

Supportive & Lifestyle Measures

• Smoking cessation programs, nicotine‑replacement therapy, or counseling.
• Alcohol reduction counseling.
• Nutrition counseling to maintain weight and address dysphagia.
• Oral care: gentle brushing, antimicrobial mouth rinses to prevent secondary infections.

Living with Labial (Cheek) Cancer

Even after successful treatment, patients face functional and psychological challenges. Practical tips include:

• Oral hygiene – brush gently after meals; use a soft‑bristled brush and alcohol‑free fluoride toothpaste.
• Dietary modifications – start with soft, high‑protein foods (smoothies, Greek yogurt, mashed potatoes) and gradually introduce tougher textures.
• Saliva management – stay hydrated; consider saliva substitutes or sugar‑free lozenges if xerostomia develops from radiation.
• Speech & swallowing therapy – early referral to a speech‑language pathologist can improve outcomes.
• Regular follow‑up – every 3‑6 months for the first 2 years, then annually; includes physical exam and imaging as indicated.
• Psychosocial support – counseling, support groups, or survivorship programs help address anxiety, depression, and body‑image concerns.
• Dental care – see a dental professional before radiation to treat any existing decay; post‑treatment, maintain routine cleanings.

Prevention

Because many risk factors are modifiable, prevention strategies can markedly lower incidence.

• Stop tobacco use – the single most effective preventive measure. Resources: quitlines, nicotine replacement, prescription medications (varenicline, bupropion).
• Limit alcohol – no more than 2 standard drinks per day for men, 1 for women.
• Avoid betel‑nut chewing – public‑health campaigns in high‑risk regions have shown reductions in oral cancer rates.
• HPV vaccination – Gardasil 9 protects against HPV‑16/18 and may reduce oral HPV‑related cancers.
• Balanced diet – at least 5 servings of fruits/vegetables daily; lycopene‑rich foods (tomatoes) have been associated with lower oral cancer risk.
• Regular dental/medical oral examinations – especially for high‑risk individuals; early detection dramatically improves survival (5‑year survival >80% for stage I vs. <30% for stage IV).<sup>[8]</sup>

Complications

If left untreated or if treatment is delayed, several serious complications can arise:

• Local invasion into the maxilla, mandible, or facial nerves causing facial disfigurement, loss of sensation, or difficulty chewing.
• Regional metastasis to cervical lymph nodes, increasing mortality.
• Airway obstruction from large tumors or post‑operative swelling.
• Pathologic fracture of the jaw when bone is infiltrated.
• Osteoradionecrosis after high‑dose radiation – bone that fails to heal, leading to chronic pain and infection.
• Chronic pain, xerostomia, dysgeusia (altered taste) affecting nutrition and quality of life.
• Second primary tumors – patients with head‑and‑neck cancer have a 5‑10% annual risk of developing another primary tumor in the aerodigestive tract.

When to Seek Emergency Care

References

1. World Health Organization. Oral Cancer Fact Sheet. WHO. 2022.
2. Mayo Clinic. Oral cavity and oropharyngeal cancer. 2023.
3. National Cancer Institute. SEER Cancer Statistics Review, 1975‑2019. 2021.
4. American Cancer Society. Head and Neck Cancers. 2023.
5. International Agency for Research on Cancer. Betel‑quid and areca nut chewing. IARC Monographs, 2020.
6. CDC. HPV and Cancer. 2022.
7. American Academy of Otolaryngology–Head and Neck Surgery. Clinical Practice Guidelines for Oral Cavity Cancer. 2022.
8. Cleveland Clinic. Oral Cancer Screening and Early Detection. 2024.

```